Pre-emptive use of aerosolized ribavirin in the treatment of asymptomatic pediatric marrow transplant patients testing positive for RSV

Bone Marrow Transplantation

Volumn 24, Issue 6, 1999, Pages 661-664

  Adams, R H ^a,b   Christenson, J C ^a   Petersen, F B ^a   Beatty, P G ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b Intermountain Blood and Marrow Transplant Program   (United States)

Author keywords

Lower respiratory tract disease; Respiratory syncytial virus; Ribavirin immunocompromised patients

Indexed keywords

RIBAVIRIN;

ADOLESCENT; AEROSOL; ARTICLE; ASPIRATION; BONE MARROW TRANSPLANTATION; CHILD; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; INFANT; INHALATIONAL DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRUS INFECTION;

EID: 0032847511     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701959     Document Type: Article

References (13)

1. Whimbey E, Englund JA, Couch RB. Community respiratory virus infections in immunocompromised patients with cancer. Am J Med 1997; 102: 10-18.
2. Bowden RA. Respiratory virus infections after marrow transplant: the Fred Hutchinson Cancer Research Center experience. Am J Med 1997; 102: 27-30.
3. Lewinsohn DM, Bowden RA, Mattson D, Crawford SW. Phase I study of intravenous ribavirin treatment of respiratory syncytial virus pneumonia after marrow transplant. Antimicrob Agents Chemother 1996; 40: 2555-2557.
4. Ljungman P. Respiratory virus infections in bone marrow transplant recipients: the European perspective. Am J Med 1997; 102: 44-47.
5. Harrington RD, Hooton RD, Hackman RC et al. An outbreak of respiratory syncytial virus in a bone marrow transplant center. J Infect Dis 1992; 165: 987-993.
6. Whimbey E, Champlin RE, Englund JA et al. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients. Bone Marrow Transplant 1995; 16: 393-399.
7. Whimbey E, Champlin RE, Couch RB et al. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis 1996; 22: 778-782.
8. McColl MD, Corser RB, Bremner J, Chopra R. Respiratory syncytial virus infection in adult BMT recipients: effective therapy with short duration nebulised ribavirin. Bone Marrow Transplant 1998; 21: 423-425.
9. Englund JA, Piedra PA, Ahn YM et al. High-dose, short-duration ribavirin aerosol therapy compared with standard ribavirin therapy in children with suspected respiratory syncytial virus infection. J Pediatr 1994; 125: 635-641.
10. Halstead DC, Todd S, Fritch G. Evaluation of five methods for respiratory syncytial virus detection. J Clin Microbiol 1990; 28: 1021-1025.
11. Committee on Infectious Diseases, Committee on Fetus and Newborn, American Academy of Pediatrics. Respiratory syncytial virus immune globulin introvenous: indications for use. Pediatrics 1997; 99: 645-650.
12. Rodriguez WJ, Grnher WC, Welhvar RC et al. Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections. Pediatrics 1997; 99: 454-461.
13. Ljungman P, Gleaves CA, Meyers JD. Respiratory virus infection in immuno-compromised patients. Bone Marrow Transplant 1989; 4: 34-40.